Skip to main content
. 2016 Nov 5;234(1):3–13. doi: 10.1007/s00213-016-4445-0

Fig. 1.

Fig. 1

Patient disposition. *patients who received at least one dose of study drug. ARI aripiprazole, ITT intent to treat, OLA olanzapine, PP1M once-monthly paliperidone palmitate, Pali ER paliperidone extended-release, QUE quetiapine, RIS risperidone